Uropathogenic Escherichia coli is the main uropathogen involved in community and hospital acquired urinary tract infections. The increased rate of resistance towards different classes of antibiotics limits the treatment options for such infections. This study aim to determine the local resistance rate against different classes of antibiotics that are commonly used in treatment of urinary tract infections. Also to determine the rate of ESBL production and the correlation with other antibiotic resistance among producing isolates.
INTRODUCTION
Urinary tract infections (UTIs) are the most common infectious disease which are affecting about 150 million cases around the world annually (Flores-Mireles, 2015) . UTIs may affect only bladder (cystitis) with localized symptoms (painful urination, urgency and frequency) or may extend to kidneys (pyelonephritis ) with more serious symptoms which can be developed into life threating septicemia (Mahon, 2015) . Uropathogenic Escherichia coli (UPEC) is considered the primary cause of the UTI. About 95% of UTIs are treated empirically (especially uncomplicated cystitis) using several classes of antibiotics such as sulphamethoxazole, fluoro-quinolones and β-lactams antibiotics (Gupta et al., 2011) . The increasing resistance rate towards different classes of antibiotics that mainly used in such infections and the emergence of multiple drug resistant (MDR) strains is considered a serious health problem limiting the available treatment options for such infections.
Extended spectrum β-lactamase (ESBL) is the primary mechanism responsible for β-lactams resistance in Enterobacteriaceae where Escherichia coli; especially those involved in UTI; represents the majority of ESBL producing Enterobacteriaceae (Rudresh and Nagarathnamma, 2011) . ESBL is plasmid mediated hydrolyzing enzymes being capable of cleavage of extended spectrum oximino-cephalosporin antibiotics and mononbactam but inhibited by β-lactamase inhibitors especially clavulanic acids (Shaikh et al., 2015) . ESBL-producing pathogen also exhibited resistance towards different classes of nonβ-lactams antibiotics which mainly due to plasmid acquisition where ESBL encoding genes enzymes can exist along with other antibiotic resistance genes (Paterson and Bonomo, 2005) .
The aim of this study to determine the overall local resistance rate towards different classes of antibiotics and determine the rate of ESBL production among UPEC isolates. Also to determine the correlation between ESBL production and antibiotic resistance among ESBL-producing isolates. Colonies from overnight cultures on Tryptone soya agar (TSA) plates (Oxoid, Hampshire, UK) were suspended into saline, the turbidity of the suspension was adjusted to be equivalent to 0.5 McFarland standard. A sterile cotton swab which moistened with the prepared inoculum was used to inoculate the surface of Mueller -Hinton Agar (MHA) plates (Oxoid, Hampshire, UK). Antibiotic discs were applied using fineend forceps and plates incubated at inverted position at 37ºC for 16-18 hrs. Inhibition zone were measured and interpreted as sensitive (S), intermediate (I) or resistant (R) according to CLSI criteria (CLSI, 2015b) .
MATERIAL and METHODS

Bacterial isolates
Phenotypic detection of ESBL production
According to CLSI guidelines, isolates with inhibition zone less than 17mm for cefpodoxime, 25mm for ceftriaxone and/or 27 mm for aztreonam are considered as a potential ESBL producing isolates (CLSI, 2015b) .
ESBL production among candidate isolates was confirmed by double disk synergy test at standard distance 20mm (DDST20) using amoxicillin-clavulanate disk (AMC 20/10μg) and three antibiotics representing third-generation cephalosporins include ceftazidime (CTZ, 30 μg ), ceftriaxone (CRO, 30 μg) and cefotaxime (CTX, 30 μg) along with cefepime (FEB, 30 μg) as a fourthgeneration cephalosporin. All antibiotic discs which were used in DDST20 were obtained from Oxoid (Hampshire, UK).
Colonies from overnight cultures on TSA plates were suspended into 0.85% saline, turbidity was adjusted to 0.5 McFarland standard and used to inoculate the surface of (MHA) plates by using a sterile cotton swab. Antibiotic discs representing 3rd and 4th were placed at a distance of 20 cm center to center from Amoxicillin-clavulanate disc which placed in the center of the plate. Plates were incubated at 37 0 c for 16-18 hrs. any enhancement or distortion of the inhibition zone of any antibiotic disc towards amoxicillin-clavulanic acid indicates ESBL production (Garrec et al., 2011) .
Statistical analysis
Statistical analysis was performed using SPSS (version 16.0) 
ESBL production
Seventy isolates were considered as potential ESBL producer in the initial antibiotic susceptibility test. Eighty percent of these isolates (56/70) were confirmed to be ESBL producer with overall percentage 50% of the total isolates. While the remaining proportion remained unconfirmed with overall percentage 12.5% of the total UPEC isolates (Figure 1 ). Antibiotic susceptibility in relation to ESBL production: ESBL producing UPEC exhibited higher resistance rate towards several antibiotic classes when compared with non-producing isolates (table. 1).
Resistance rate against doxycycline was high in both ESBLproducing and non-producing isolates (99.96% and 83.8%, respectively..). ESBL producing isolates exhibited statistically higher resistance rate especially against sulphamethoxazoletrimethoprim and fluoro-quinolones (67.8 % and 63 %, respectively) when compared with non-producing isolates (35.7% and 19 %, respectively 
DISCUSSION
Escherichia coli is the most frequent bacterium involved in UTIs including uncomplicated cystitis and pyelonephritis. The problem of empirical treatment besides self-medication and the misusing of antimicrobial agents which present in many countries like ours has a great impact in increasing the local resistance rate with increasing risk of therapy failure (Michael et al. , 2014) .
Several antibiotic classes such as nitrofurantoin, sulphamethoxazoletrimethoprim, fluoro-quinolones are considered appropriate choices for UTIs treatment especially uncomplicated cystitis (Gupta et al., 2011) . But the increased local resistance rate towards them especially sulphamethoxazole-trimethoprim and fluoro-quinolones limit their role in the treatment.
Our result demonstrated increased resistance rate towards sulphamethoxazole (54%) and fluoro-quinolones (48.6% -50.5%) which came in agreement with previous studies (Das et al., 2009; Shariff et al., 2013; Neamati et al., 2015) .
Also UPEC exhibited a reduced susceptibility towards β-lactams including extenetded spectrum cephalosporins that 50% of tested isolates were confirmed to be ESBL-producers. Our results came in agreement with two similar studies performed in Egypt where the first study stated that ESBL production was observed in 54.6% of UPEC isolates (Morsi and Tash, 2016) . And the other study demonstrated that 36% of UPEC isolates were found to be ESBL producer (Elsayed et al., 2017) confirming the increased rate of ESBL producing UPEC in Egypt.
ESBL production not only restricts the using of β lactams antibiotics but also extends to include other classes due to the presence of antibiotic co-resistance among producing strains. Our result demonstrated that the majority of ESBL producing isolates (85.7 %) exhibited multiple drug resistance nature.
ESBL producing isolates are mainly resistant to doxycycline and exhibited statistically high rate of resistance especially towards sulphamethoxazole-trimethoprim and fluoro-quinolones (67.8 % and 63%, respectively) that ESBL producing isolates were either being resistance to sulphamethoxazole-trimethoprim or fluoroquinolones along with resistance towards other antibiotics such as gentamicin (30.3%). Moreover, 47.4% of ESBL isolates were resistance to both sulphamethoxazoletrimethoprim and fluoro-quinolones. ISSN 1110 This observed high rate antibiotic coresistance among ESBL producing isolates came in agreement with other studies which is appeared to be a world-wide trend with slight variation between countries (Azap et al., 2010; El bouamri et al., 2014; Ali et al., 2016) .
However, ESBL producing isolates exhibited high susceptibility towards other antibiotics including carbapenems (imipenem and meropenem) piperacillintazobactam besides nitrofurantoin which can be used in the treatment of these multiple antibiotic resistant ESBL producing UPEC.
Carbapenem consider the drug of choice for the treatment of ESBL producing isolates that on study reported that >98% of the ESBL-producing E. coli are susceptible to this antibiotic class (Perez et al.,2007) . But the using of carbapenem-sparing agents (with comparable activity) against ESBL producing isolates such as cefepime and fosfomycine is a good option to avoid the emergence of carbapenemase producing strains (Pullukcu et al., 2007; Kim et al., 2018) .
Conclusion
ESBL producing UPEC exhibited multiple antibiotic resistance nature with statistically high resistance rate to other antibiotic classes. This observed antibiotic coexistence is the result of plasmid acquisition carrying ESBL encoding genes along with other antibiotic resistance genes making the available treatment options is limited. 
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